Expanded-Access Use of Elamipretide in a Patient with Membrane Protein-Associated NeurodegenerationShort Running Title: Elamipretide Treatment in MPAN PatientJorge Patino1, Anna Haertling Clearman2, Lindsey Miller2, Mary Kay Koenig21. University of Texas McGovern Medical School, Department of Neurology, Houston, TX2. University of Texas McGovern Medical School, Department of Pediatrics, Division of Child & Adolescent Neurology, Center for the Treatment of Pediatric Neurodegenerative Disease, Houston, TXCorresponding Author: Jorge Patino, [email protected]